| - SMTL ID
- 4cew.1
- Ligands
- 4-[3-[(3s)-5-[4-[(e)-ethoxyiminomethyl]phenoxy]-3-methyl-pentyl]-2-oxidanylidene-imidazolidin-1-yl]pyridine-2-carboxamide
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-1-1-1-1-mer
|
| - SMTL ID
- 4cew.2
- Ligands
- 4-[3-[(3s)-5-[4-[(e)-ethoxyiminomethyl]phenoxy]-3-methyl-pentyl]-2-oxidanylidene-imidazolidin-1-yl]pyridine-2-carboxamide
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-5-5-5-5-mer
|
| - SMTL ID
- 4cew.3
- Ligands
- 4-[3-[(3s)-5-[4-[(e)-ethoxyiminomethyl]phenoxy]-3-methyl-pentyl]-2-oxidanylidene-imidazolidin-1-yl]pyridine-2-carboxamide
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-6-6-6-6-mer
|
| - SMTL ID
- 4cew.4
- Ligands
- 4-[3-[(3s)-5-[4-[(e)-ethoxyiminomethyl]phenoxy]-3-methyl-pentyl]-2-oxidanylidene-imidazolidin-1-yl]pyridine-2-carboxamide
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-1-1-1-1-mer
|